Related Experiment Video
Updated: Nov 28, 2025
11:12
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
701
Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived Lymphomas
Martin Böttcher1, Rebecca Baur1, Andrej Stoll1
1Department of Medicine 5 for Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Frontiers in Oncology
|November 30, 2020
Summary
Metabolic reprogramming in B-cell lymphomas alters the tumor microenvironment, impacting anti-tumor immunity. Understanding these metabolic changes is crucial for developing new therapies for relapsed and refractory lymphomas.
Area of Science:
- Oncology
- Immunology
- Metabolism
Background:
- B-cell lymphomas are diverse malignancies with unmet needs in relapsed/refractory disease.
- Immune-based therapies are increasingly important for treating lymphomas.
- Metabolic reprogramming and immune escape are key cancer hallmarks.
Purpose of the Study:
- To review molecular events driving metabolic alterations in B-cell lymphomas.
- To explore the impact of these metabolic changes on anti-tumor immunity.
- To inform the development of novel therapeutic strategies.
Main Methods:
- Review of existing literature on lymphoma metabolism and tumor microenvironment.
- Analysis of molecular mechanisms underlying metabolic reprogramming in B-cell lymphomas.
- Examination of how metabolic alterations affect immune cell function and anti-tumor responses.
Main Results:
- Tumor metabolism promotes lymphoma survival, proliferation, and therapeutic resistance.
- Altered tumor cell metabolism impacts both local and systemic anti-tumor immunity.
- Metabolic reprogramming by lymphomas can lead to immune tolerance by affecting immune cell fitness and function.
Conclusions:
- Metabolic alterations in B-cell lymphomas significantly influence the anti-tumor immune response.
- Understanding the interplay between lymphoma metabolism and immunity is critical for therapeutic innovation.
- Targeting metabolic pathways may offer new avenues for treating refractory B-cell lymphomas.
Related Concept Videos
01:24B Cell Activation and Differentiation
15.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.4K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K